TY - JOUR
T1 - Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD
T2 - Development and validation in two middle-aged population-based cohorts
AU - TAHS and ECRHS Investigator Groups
AU - Perret, Jennifer L.
AU - Vicendese, Don
AU - Simons, Koen
AU - Jarvis, Debbie L.
AU - Lowe, Adrian J.
AU - Lodge, Caroline J.
AU - Bui, Dinh S.
AU - Tan, Daniel
AU - Burgess, John A.
AU - Erbas, Bircan
AU - Bickerstaffe, Adrian
AU - Hancock, Kerry
AU - Thompson, Bruce R.
AU - Hamilton, Garun S.
AU - Adams, Robert
AU - Benke, Geza P.
AU - Thomas, Paul S.
AU - Frith, Peter
AU - Mcdonald, Christine F.
AU - Blakely, Tony
AU - Abramson, Michael J.
AU - Walters, E. Haydn
AU - Minelli, Cosetta
AU - Dharmage, Shyamali C.
N1 - Publisher Copyright:
© 2021 Author(s) (or their employer(s)).
PY - 2021/12/2
Y1 - 2021/12/2
N2 - Background: Classifying individuals at high chronic obstructive pulmonary disease (COPD)-risk creates opportunities for early COPD detection and active intervention. Objective: To develop and validate a statistical model to predict 10-year probabilities of COPD defined by post-bronchodilator airflow obstruction (post-BD-AO; forced expiratory volume in 1 s/forced vital capacity<5th percentile). Setting: General Caucasian populations from Australia and Europe, 10 and 27 centres, respectively. Participants: For the development cohort, questionnaire data on respiratory symptoms, smoking, asthma, occupation and participant sex were from the Tasmanian Longitudinal Health Study (TAHS) participants at age 41-45 years (n=5729) who did not have self-reported COPD/emphysema at baseline but had post-BD spirometry and smoking status at age 51-55 years (n=2407). The validation cohort comprised participants from the European Community Respiratory Health Survey (ECRHS) II and III (n=5970), restricted to those of age 40-49 and 50-59 with complete questionnaire and spirometry/smoking data, respectively (n=1407). Statistical method: Risk-prediction models were developed using randomForest then externally validated. Results: Area under the receiver operating characteristic curve (AUC ROC) of the final model was 80.8% (95% CI 80.0% to 81.6%), sensitivity 80.3% (77.7% to 82.9%), specificity 69.1% (68.7% to 69.5%), positive predictive value (PPV) 11.1% (10.3% to 11.9%) and negative predictive value (NPV) 98.7% (98.5% to 98.9%). The external validation was fair (AUC ROC 75.6%), with the PPV increasing to 17.9% and NPV still 97.5% for adults aged 40-49 years with ≥1 respiratory symptom. To illustrate the model output using hypothetical case scenarios, a 43-year-old female unskilled worker who smoked 20 cigarettes/day for 30 years had a 27% predicted probability for post-BD-AO at age 53 if she continued to smoke. The predicted risk was 42% if she had coexistent active asthma, but only 4.5% if she had quit after age 43. Conclusion: This novel and validated risk-prediction model could identify adults aged in their 40s at high 10-year COPD-risk in the general population with potential to facilitate active monitoring/intervention in predicted 'COPD cases' at a much earlier age.
AB - Background: Classifying individuals at high chronic obstructive pulmonary disease (COPD)-risk creates opportunities for early COPD detection and active intervention. Objective: To develop and validate a statistical model to predict 10-year probabilities of COPD defined by post-bronchodilator airflow obstruction (post-BD-AO; forced expiratory volume in 1 s/forced vital capacity<5th percentile). Setting: General Caucasian populations from Australia and Europe, 10 and 27 centres, respectively. Participants: For the development cohort, questionnaire data on respiratory symptoms, smoking, asthma, occupation and participant sex were from the Tasmanian Longitudinal Health Study (TAHS) participants at age 41-45 years (n=5729) who did not have self-reported COPD/emphysema at baseline but had post-BD spirometry and smoking status at age 51-55 years (n=2407). The validation cohort comprised participants from the European Community Respiratory Health Survey (ECRHS) II and III (n=5970), restricted to those of age 40-49 and 50-59 with complete questionnaire and spirometry/smoking data, respectively (n=1407). Statistical method: Risk-prediction models were developed using randomForest then externally validated. Results: Area under the receiver operating characteristic curve (AUC ROC) of the final model was 80.8% (95% CI 80.0% to 81.6%), sensitivity 80.3% (77.7% to 82.9%), specificity 69.1% (68.7% to 69.5%), positive predictive value (PPV) 11.1% (10.3% to 11.9%) and negative predictive value (NPV) 98.7% (98.5% to 98.9%). The external validation was fair (AUC ROC 75.6%), with the PPV increasing to 17.9% and NPV still 97.5% for adults aged 40-49 years with ≥1 respiratory symptom. To illustrate the model output using hypothetical case scenarios, a 43-year-old female unskilled worker who smoked 20 cigarettes/day for 30 years had a 27% predicted probability for post-BD-AO at age 53 if she continued to smoke. The predicted risk was 42% if she had coexistent active asthma, but only 4.5% if she had quit after age 43. Conclusion: This novel and validated risk-prediction model could identify adults aged in their 40s at high 10-year COPD-risk in the general population with potential to facilitate active monitoring/intervention in predicted 'COPD cases' at a much earlier age.
KW - COPD epidemiology
KW - clinical epidemiology
UR - http://www.scopus.com/inward/record.url?scp=85121030438&partnerID=8YFLogxK
U2 - 10.1136/bmjresp-2021-001138
DO - 10.1136/bmjresp-2021-001138
M3 - Article
AN - SCOPUS:85121030438
SN - 2052-4439
VL - 8
JO - BMJ Open Respiratory Research
JF - BMJ Open Respiratory Research
IS - 1
M1 - e001138
ER -